Plasma extracellular vesicle cargo microRNAs are associated with heart failure and cardiovascular death following acute coronary syndrome
Worawan B. Limpitikul(Massachusetts General Hospital), Saumya Das(Harvard University), Nedyalka Valkov(Massachusetts General Hospital), Ravi V. Shah(Vanderbilt University), Michael G. Silverman(Harvard University), Elizabeth Hutchins(Translational Genomics Research Institute), Marta García-Contreras(University Hospital Regensburg), Marc S. Sabatine(Brigham and Women's Hospital), Eric Alsop(Translational Genomics Research Institute), James L. Januzzi(Harvard University), Ashish Yeri(Q Therapeutics (United States)), Anthony Rosenzweig(Stanley Medical Research Institute), David A. Morrow(University of California, San Francisco), Priyanka Gokulnath(Massachusetts General Hospital), Michail Spanos(Harvard University), Raymond Y. Kwong(Broad Institute), Fernando Camacho Garcia(Massachusetts General Hospital), Claire Lin(Harvard University), Guoping Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Kendall Jensen(Translational Genomics Research Institute), Kriti Bomb(Massachusetts General Hospital), Jeong‐Gun Park(Brigham and Women's Hospital)
Cited by 5
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
|New England Journal of Medicine|2017|6k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
|Journal of the American College of Cardiology|2014|3.6k